602 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
22 Not yet recruiting Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Conditions: Functional Pancreatic Neuroendocrine Tumor;   Malignant Somatostatinoma;   Merkel Cell Carcinoma;   Metastatic Adrenal Gland Pheochromocytoma;   Metastatic Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2B;   Neuroendocrine Neoplasm;   Non-Functional Pancreatic Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adrenal Gland Pheochromocytoma;   Recurrent Merkel Cell Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor;   Stage III Adrenal Cortex Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IIIA Merkel Cell Carcinoma;   Stage IIIB Merkel Cell Carcinoma;   Stage IV Adrenal Cortex Carcinoma;   Stage IV Merkel Cell Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Thymic Carcinoid Tumor;   VIP-Producing Neuroendocrine Tumor;   Well Differentiated Adrenal Cortex Carcinoma;   Zollinger Ellison Syndrome
Interventions: Drug: Capecitabine;   Drug: Temozolomide;   Drug: Veliparib;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
23 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid
24 Recruiting A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: SOX Sequential S-1;   Drug: SOX;   Drug: TEGAFOX Sequential S-1.
25 Recruiting Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients
Condition: Gastric Cancer
Intervention: Dietary Supplement: preoperative oral carbohydrate drink
26 Not yet recruiting Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
Conditions: Pancreatic Cancer;   Esophageal Cancer;   Gastric Cancer
Interventions: Other: Usual Care;   Other: Perioperative Geriatrics Intervention
27 Recruiting A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Condition: Gastritis
Interventions: Device: The eradication times of the patients;   Device: The result of 13C-urea breath test after treatment
28 Not yet recruiting Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGC
Condition: Gastric Cancer
Interventions: Procedure: Vagus nerve-preserving Robot-assisted Gastrectomy;   Procedure: Conventional Robot-assisted Gastrectomy
29 Not yet recruiting Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Trastuzumab + NK cells
30 Recruiting Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer
Conditions: Obesity;   Gastric Cancer
Interventions: Device: AFA group (successive patients);   Other: BMI group (successive patients)
31 Not yet recruiting Role of Probe-based Confocal Laser Endomicroscopy Targeted Biopsy in the Molecular Study of Undifferentiated Gastric Cancer
Condition: Undifferentiated Gastric Cancer
Interventions: Device: GastroFlex UHD, Cellvizio; Mauna Kea Technologies, Paris, France;   Device: white light endoscopy (WLE)
32 Recruiting Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy
Conditions: Doxorubicin Induced Cardiomyopathy;   Breast Cancer;   Gastric Cancer;   Leukemia
Intervention: Other: Exercise
33 Not yet recruiting Chemoprevention of Gastric Carcinogenesis
Conditions: Gastric Cancer;   Gastric Intestinal Metaplasia
Interventions: Drug: Eflornithine;   Other: Eflornithine placebo
34 Not yet recruiting Laparoscopic Versus Open Resection of Cancer Stomach
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic gastrectomy;   Procedure: Open gastrectomy
35 Recruiting Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours
Condition: Gastroenteropancreatic Neuroendocrine Tumours
Intervention:
36 Not yet recruiting Helicobacter Pylori Genome Project
Conditions: Gastric Cancer;   Non-Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
37 Recruiting Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy
Condition: Gastric Cancer
Interventions: Device: gastroduodenal stent placement;   Procedure: gastrojejunostomy
38 Not yet recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
Conditions: Chronic Atrophic Gastritis;   Intestinal Metaplasia of Gastric Mucosa
Interventions: Drug: Curcumin;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment
39 Recruiting Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score
Condition: Gastric Adenocarcinoma
Intervention:
40 Not yet recruiting Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial
Conditions: Oesophageal Cancer;   Gastric Cancer
Interventions: Procedure: prehabilitation;   Other: nutritional support

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years